HIV Incidence Low Among Women With High PrEP Adherence, Study Finds

Infectious Disease Advisor (4/24, Nye) reports, “The incidence of HIV infection is very low among women who maintain consistently high levels of adherence to pre-exposure prophylaxis (PrEP) with emtricitabine (FTC) and tenofovir disoproxil fumarate (TDF), according to findings published in JAMA.” In the study, “compared with patients aged 25 years and older, those younger than 25 were less likely to exhibit consistently high adherence to daily PrEP, consistently high adherence to 4 to 6 weekly doses, or dynamic adherence.”